Correlation Between Relmada Therapeutics and NewAmsterdam Pharma

Can any of the company-specific risk be diversified away by investing in both Relmada Therapeutics and NewAmsterdam Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Relmada Therapeutics and NewAmsterdam Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Relmada Therapeutics and NewAmsterdam Pharma, you can compare the effects of market volatilities on Relmada Therapeutics and NewAmsterdam Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Relmada Therapeutics with a short position of NewAmsterdam Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Relmada Therapeutics and NewAmsterdam Pharma.

Diversification Opportunities for Relmada Therapeutics and NewAmsterdam Pharma

-0.65

Correlation Coefficient

Relmada Therapeutics  NewAmsterdam Pharma

Excellent diversification

The 3 months correlation between Relmada and NewAmsterdam is -0.65. Overlapping area represents the amount of risk that can be diversified away by holding Relmada Therapeutics and NewAmsterdam Pharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on NewAmsterdam Pharma and Relmada Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Relmada Therapeutics are associated (or correlated) with NewAmsterdam Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of NewAmsterdam Pharma has no effect on the direction of Relmada Therapeutics i.e., Relmada Therapeutics and NewAmsterdam Pharma go up and down completely randomly.

Pair Corralation between Relmada Therapeutics and NewAmsterdam Pharma

Given the investment horizon of 90 days Relmada Therapeutics is expected to generate 5.45 times more return on investment than NewAmsterdam Pharma. However, Relmada Therapeutics is 5.45 times more volatile than NewAmsterdam Pharma. It trades about 0.07 of its potential returns per unit of risk. NewAmsterdam Pharma is currently generating about -0.27 per unit of risk. If you would invest  35.00  in Relmada Therapeutics on October 20, 2024 and sell it today you would earn a total of  2.00  from holding Relmada Therapeutics or generate 5.71% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

Relmada Therapeutics  vs.  NewAmsterdam Pharma

Relmada Therapeutics

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Relmada Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of conflicting performance in the last few months, the Stock's primary indicators remain rather sound which may send shares a bit higher in February 2025. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.

NewAmsterdam Pharma

Risk-Adjusted Performance

6 of 100

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in NewAmsterdam Pharma are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively weak primary indicators, NewAmsterdam Pharma unveiled solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Relmada Therapeutics and NewAmsterdam Pharma

The main advantage of trading using opposite Relmada Therapeutics and NewAmsterdam Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Relmada Therapeutics position performs unexpectedly, NewAmsterdam Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in NewAmsterdam Pharma will offset losses from the drop in NewAmsterdam Pharma's long position.

The idea behind Relmada Therapeutics and NewAmsterdam Pharma pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the ETF Categories module to list of ETF categories grouped based on various criteria, such as the investment strategy or type of investments.